Correction to: Zavegepant: First Approval

被引：0

|

作者：

Sohita Dhillon

机构：

[1] Springer Nature,

来源：

Drugs | 2023年 / 83卷 / 11期

关键词：

D O I：

10.1007/s40265-023-01915-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1063 / 1063

相关论文

共 50 条

[1] Zavegepant: First Approval
Sohita Dhillon
[J]. Drugs, 2023, 83 : 825 - 831
[2] Zavegepant: First Approval
Dhillon, Sohita
[J]. DRUGS, 2023, 83 (09) : 825 - 831
[3] Zavegepant: First Approval (vol 83, pg 825, 2023)
Dhillon, Sohita
[J]. DRUGS, 2023,
[4] Correction: Aponermin: First Approval
Sohita Dhillon
[J]. Drugs, 2024, 84 (4) : 487 - 487
[5] Correction to: Isatuximab: First Approval
Sohita Dhillon
[J]. Drugs, 2020, 80 (9) : 913 - 913
[6] Correction to: Filgotinib: First Approval
Sohita Dhillon
Susan J. Keam
[J]. Drugs, 2021, 81 (2) : 297 - 297
[7] Correction to: Spesolimab: First Approval
Hannah A. Blair
[J]. Drugs, 2023, 83 (1) : 103 - 103
[8] Correction to: Oliceridine: First Approval
Anthony Markham
[J]. Drugs, 2020, 80 (17) : 1871 - 1871
[9] Correction to: Nedosiran: First Approval
Yahiya Y. Syed
[J]. Drugs, 2024, 84 (2) : 255 - 255
[10] Correction to: Selpercatinib: First Approval
Anthony Markham
[J]. Drugs, 2021, 81 (1) : 181 - 181

← 1 2 3 4 5 →